Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 350 across all filing types
Latest filing 2025-04-10 Regulatory Filings
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Thymol Supply Agreement For Bee Health
Regulatory Filings Classification · 98% confidence The document is a press release issued via the London Stock Exchange's RNS (Regulatory News Service) announcing a commercial agreement between Eden Research plc and Véto-pharma to supply thymol for bee health applications. It does not fit into specific categories like financial reports, board changes, or shareholder voting results. As it is a general corporate announcement regarding business operations and partnerships, it falls under the 'Regulatory Filings' (RNS) category.
2025-04-10 English
Director/PDMR Shareholdings
Director's Dealing Classification · 100% confidence The document is an official announcement from Eden Research plc regarding the purchase of company shares by its CEO and CFO. It explicitly mentions 'Director/PDMR Shareholdings' and provides detailed tables in accordance with the EU Market Abuse Regulation (MAR) regarding transactions by persons discharging managerial responsibilities. This fits the definition of a Director's Dealing (DIRS) report.
2025-04-01 English
Appointment of Distribution Partner in Kenya
Regulatory Filings Classification · 100% confidence The document is a press release issued via the London Stock Exchange's RNS (Regulatory News Service) announcing a new commercial partnership (appointment of a distribution partner in Kenya) for Eden Research plc. Since this is a corporate announcement regarding business operations and does not fit into specific categories like M&A, financial results, or director dealings, it falls under the general regulatory filing category.
2025-03-24 English
Appointment of Joint Broker
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 9768Z' and is dated 09 March 2025. It announces the 'Appointment of Joint Broker' and includes contact details for the company, the nominated advisor/joint broker (Cavendish), and the new joint broker (Oberon). This type of announcement, which details changes in corporate advisory/brokerage relationships, is a standard regulatory disclosure. Since it is a specific corporate action announcement disseminated via the RNS system, and it doesn't fit the specific categories like Director's Dealing (DIRS), Management Change (MANG), or Capital Change (CAP), the most appropriate general category for a non-standard, mandatory regulatory disclosure disseminated via RNS is 'Regulatory Filings' (RNS). It is not a report itself, nor is it a management change, dividend notice, or earnings release.
2025-03-10 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is a regulatory announcement identified by the 'RNS Number' and the mention of 'RNS, the news service of the London Stock Exchange'. The content explicitly details a 'Director/PDMR Shareholding' transaction, specifically a purchase of Ordinary Shares by the Non-Executive Chairman, Lykele van der Broek. This type of insider transaction disclosure, made in accordance with the EU Market Abuse Regulation (MAR), directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the core subject matter is the insider trade, making DIRS the most specific classification over the general RNS fallback.
2025-03-05 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The core content details a 'Director/PDMR Shareholding' transaction, specifically a purchase of ordinary shares by a Non-Executive Director, followed by the required MAR disclosure table. This type of insider transaction disclosure, when disseminated via the London Stock Exchange's RNS system, falls under the category of Director's Dealing (DIRS). Although it is an RNS announcement, DIRS is a more specific classification than the general RNS fallback.
2025-03-05 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.